Navigation Links
Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation

MAPLE GROVE, Minn., May 22, 2012 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. announced today that Senior National Account Manager, Dave Zitnak received the prestigious McKesson Branded Pharmaceutical Representative of the Year Award at the annual McKesson National Sales Conference in Las Vegas, NV on May 8, 2012.  The award was presented by Greg Yonko, Senior Vice President of Purchasing at McKesson. 


San Francisco, CA-based McKesson, one of the largest pharmaceutical distributors in North America, distributing one-third of the medicines used every day, selected Zitnak as its Branded Pharmaceutical Representative of the Year for consistently demonstrating the attributes of collaboration, problem solving and ability to create win-win opportunities. 

Zitnak recently celebrated his 20th year with Upsher-Smith and has been calling on McKesson for six years.  He began his career as a sales representative, moving into positions of increasing responsibility including District Sales Manager and Manager of Sales Operations.

"We are honored that McKesson recognized Dave with its prestigious Branded Pharmaceutical Representative of the Year Award," said Tom Burke, COO, Upsher-Smith Laboratories.  "Dave's commitment to his customers has consistently earned him the reputation of being a highly trusted partner in the industry and reflects Upsher-Smith's unwavering commitment to our partnerships with all of our wholesaler customers."

About Upsher-Smith
Upsher-Smith Laboratories, Inc. is a privately held, U.S.-based company devoted to improving health and advancing wellness since 1919.  Upsher-Smith demonstrates its commitment to meeting the healthcare needs of its customers by developing, producing and marketing consumer and prescription products.  In addition to its strong heritage in generics, Upsher-Smith's branded businesses focus on women's health, dermatology and CNS therapeutic areas.  For additional information, visit

About McKesson
McKesson Corporation, currently ranked 14th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. We partner with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. For more information, visit

SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate
2. Upsher-Smith Presents Updated Extended-Release Topiramate Data (USL255) at AES Meeting
3. Upsher-Smith Laboratories Named Manufacturer of the Year by AmerisourceBergen Corporation
4. PK Study Comparing Upsher-Smiths Extended-Release Topiramate Formulation (USL255) With Topamax® Published Online In Epilepsia
5. Upsher-Smith Laboratories Begins Phase III Study of Intranasal Midazolam for Rescue Treatment of Seizure Clusters in Epilepsy Patients
6. Upsher-Smith Receives Prestigious DIANA Award for Third Year in a Row
7. Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall
8. Upsher-Smith Introduces Nexa™ Select With More Plant-Based DHA Than Any Other Once-Daily Single Gel Capsule Rx Prenatal Vitamin
9. Upsher-Smith Laboratories Announces Initiation of Open-Label Extension Study of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
10. Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem® 10 mcg
11. Upsher-Smith Laboratories Adds ITI-111 (Nasal Midazolam) to CNS Development Pipeline
Post Your Comments:
(Date:11/27/2015)... 27, 2015 --> ... go online. The potential to save costs, improve treatment ... far from fully exploited as yet. Here, particular emphasis ... either via mobile tablet or directly at the patients, ... ) -->      (Photo: ...
(Date:11/26/2015)... India , November 27, ... --> --> ... personal emergency response system (PERS) ... steadily for 5 years with ... region expected to see a ...
(Date:11/26/2015)... November 26, 2015 --> ... use SyMRI to find optimal contrast weighting of MRI ... and has signed a research agreement with SyntheticMR in order ... Using SyMRI, it is possible to generate multiple contrast images ... the patient has left, thus making it possible to both ...
Breaking Medicine Technology:
(Date:11/29/2015)... San Jose, CA (PRWEB) , ... November 29, 2015 , ... ... Bay Area, is proud to announce their December, 2015, featured apartment community: Epic. In ... looking for corporate housing in the tight Bay Area rental market to efficiently find ...
(Date:11/28/2015)... , ... November 28, 2015 , ... Trying to relax ... created the COUCH BUDDY. "I conceived of this design due to personal experience with ... couch users. It promotes relaxation and convenience, as well as increases support. It also ...
(Date:11/27/2015)... , ... November 28, 2015 , ... There is only ... outperform our billings from last year? , This question has not been an easy ... coming to the retirement age and the younger workforce don’t share the same discipline ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... way that they are handling security in light of the recent terrorist attacks in ... an attempt to stop an attack from reaching U.S. soil. Especially around special events ...
(Date:11/27/2015)... ... November 27, 2015 , ... An inventor, from ... dispense prescription medications at home, so he invented the patent-pending ELECTRONIC M.D. , ... prescription medications. In doing so, it could help to prevent potential overdose situations. ...
Breaking Medicine News(10 mins):